Marc Shamier

Amsterdam University Medical Centers

Netherlands

Research Interests

Explore related searches

Professors in Netherlands Professors in Immunology Immunology professors in Netherlands

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (6)

Year:

2024

Year:

2024

Year:

2023

Year:

2022

Year:

2021

Year:

2021

Collaborators (6)

Luca M. Zaeck

Erasmus University Rotterdam

NETHERLANDS

View details

Kai Jonas

University of Maastricht

NETHERLANDS

View details

Eric C.M. van Gorp

University of Amsterdam

NETHERLANDS

View details

Martin van Royen

Assistant Professor

Erasmus MC

NETHERLANDS

View details

Bas B. Oude Munnink

NETHERLANDS

View details

David van de Vijver

Erasmus University Rotterdam

NETHERLANDS

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Marc Shamier

Research Interests

Explore related searches

Contact this professor

Articles (6)

Scenarios of future mpox outbreaks among men who have sex with men

Orthopoxvirus-specific antibodies wane to undetectable levels 1 year after MVA-BN vaccination of at-risk individuals, the Netherlands, 2022 to 2023

Low levels of monkeypox virus-neutralizing antibodies after MVA-BN vaccination in healthy individuals

Diminished amplification of SARS-CoV-2 ORF1ab in a commercial dual-target qRT-PCR diagnostic assay

SARS-CoV-2 variants of concern partially escape humoral but not T-cell responses in COVID-19 convalescent donors and vaccinees.

The role of antibody indexes in clinical virology.

Collaborators (6)

Luca M. Zaeck

Kai Jonas

Eric C.M. van Gorp

Martin van Royen

Bas B. Oude Munnink

David van de Vijver

Make your next move.

Marc Shamier

Research Interests

Explore related searches

Contact this professor

Articles (6)

Scenarios of future mpox outbreaks among men who have sex with men

Orthopoxvirus-specific antibodies wane to undetectable levels 1 year after MVA-BN vaccination of at-risk individuals, the Netherlands, 2022 to 2023

Low levels of monkeypox virus-neutralizing antibodies after MVA-BN vaccination in healthy individuals

Diminished amplification of SARS-CoV-2 ORF1ab in a commercial dual-target qRT-PCR diagnostic assay

SARS-CoV-2 variants of concern partially escape humoral but not T-cell responses in COVID-19 convalescent donors and vaccinees.

The role of antibody indexes in clinical virology.

Collaborators (6)

Luca M. Zaeck

Kai Jonas

Eric C.M. van Gorp

Martin van Royen

Bas B. Oude Munnink

David van de Vijver

Make your next move.

Orthopoxvirus-specific antibodies wane to undetectable levels 1 year after MVA-BN vaccination of at-risk individuals, the Netherlands, 2022 to 2023